GGrantIndex
← Leaderboards

Gustavo Mostoslavsky

Boston Medical Center

$8,886,292
Attributed
$22,618,960
Total exposure
10
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200825
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,618,960 · 10

By mechanism

U01$8,307,994 · 1
R01$6,980,125 · 3
RC2$2,716,079 · 1
R24$2,698,156 · 1
R21$1,916,606 · 4

Most similar at Boston Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Induced Pluripotent Stem Cell

Research focus

Induced Pluripotent Stem CellCellsBaseIn VitroGenesCell LineProductionMolecularFutureResponseMorbidity - Disease RateTechnologyIn VivoOrganoidsPathway InteractionsGeneticAffectSyndromeProteinsImmuneMutantPhenotypePlayMalignant Neoplasms

Grant awards (33)

Mechanisms of Neurodegeneration in Hereditary Prion Diseases$869,478
R01 · FY2025 · NS
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection$664,379
R01 · FY2024 · DA
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection$677,030
R01 · FY2023 · DA
Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids$212,500
R21 · FY2023 · AI · contact PI
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection$689,563
R01 · FY2022 · DA
Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids$273,750
R21 · FY2022 · AI · contact PI
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection$701,970
R01 · FY2021 · DA
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection$730,514
R01 · FY2020 · DA
Modeling prion diseases using human iPSC-derived neurons$487,875
R21 · FY2019 · NS
A National Resource for Lung disease-specific iPS cells$541,294
R24 · FY2018 · HL
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$538,885
R01 · FY2018 · CA
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$118,831
R01 · FY2018 · CA
A National Resource for Lung disease-specific iPS cells$541,294
R24 · FY2017 · HL
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$538,885
R01 · FY2017 · CA
Antiviral responses in iPSC-derived human primary cells to Ebola virus infection$210,375
R21 · FY2017 · AI
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$118,831
R01 · FY2017 · CA
A National Resource for Lung disease-specific iPS cells$541,294
R24 · FY2016 · HL
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$420,054
R01 · FY2016 · CA
Antiviral responses in iPSC-derived human primary cells to Ebola virus infection$270,000
R21 · FY2016 · AI
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$55,498
R01 · FY2016 · CA
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells$1,859,717
U01 · FY2015 · HL
A National Resource for Lung disease-specific iPS cells$533,174
R24 · FY2015 · HL
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$420,054
R01 · FY2015 · CA
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells$2,231,289
U01 · FY2014 · HL
A National Resource for Lung disease-specific iPS cells$541,100
R24 · FY2014 · HL
The Role of SIRT6 and Metabolism in APC Mediated Tumorigenesis$436,153
R01 · FY2014 · CA
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells$2,200,128
U01 · FY2013 · HL
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells$1,218,858
U01 · FY2012 · HL
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells$798,002
U01 · FY2011 · HL
Characterization of human hematopoietic and endodermal progenitors derived from i$1,319,537
RC2 · FY2010 · HL
Characterization of human hematopoietic and endodermal progenitors derived from i$1,396,542
RC2 · FY2009 · HL
Study of Rag1 hypomorphic mice and their rescue by lentiviral gene transfer$211,086
R21 · FY2009 · HD · contact PI
Study of Rag1 hypomorphic mice and their rescue by lentiviral gene transfer$251,020
R21 · FY2008 · HD · contact PI